PAVmed Inc [PAVM] stock prices are down -8.88% to $10.98 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The PAVM shares have gain 19.48% over the last week, with a monthly amount glided 18.68%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
PAVmed Inc [NASDAQ: PAVM] stock has seen the most recent analyst activity on March 30, 2021, when Cantor Fitzgerald initiated its Overweight rating and assigned the stock a price target of $8. Previously, Ascendiant Capital Markets started tracking the stock with Buy rating on November 05, 2020, and set its price target to $5. On June 28, 2018, Maxim Group initiated with a Buy rating and assigned a price target of $5 on the stock.
The stock price of PAVmed Inc [PAVM] has been fluctuating between $6.00 and $28.44 over the past year. PAVmed Inc [NASDAQ: PAVM] shares were valued at $10.98 at the most recent close of the market.
Analyzing the PAVM fundamentals
The PAVmed Inc [NASDAQ:PAVM] reported sales of 0.03M for trailing twelve months, representing a drop of -99.50%. Gross Profit Margin for this corporation currently stands at -6.69% with Operating Profit Margin at -696.28%, Pretax Profit Margin comes in at 49.31%, and Net Profit Margin reading is 106.72%. To continue investigating profitability, this company’s Return on Assets is posted at 0.08, Equity is 0.1 and Total Capital is -0.73. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.26.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that PAVmed Inc [NASDAQ:PAVM]’s Current Ratio is 0.40. Further, the Quick Ratio stands at 0.40, while the Cash Ratio is 0.3. Considering the valuation of this stock, the price to sales ratio is 389.06, the price to book ratio is 1.00.
